The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with RaplA and a GTP analogue

The X-ray crystal structure of the complex between the Ras-related protein RaplA in the GTP-analogue (GppNHp) form and the Ras-binding domain (RBD) of the Ras effector molecule c-Raf1, a Ser/Thr-specific protein kinase, has been solved to a resolution of 2.2 Å. It shows that RBD has the ubiquitin superfold and that the structure of RaplA is very similar to that of Ras. The interaction between the two proteins is mediated by an apparent central antiparallel β-sheet formed by strands B1–B2 from RBD and strands β2–β3 from RaplA. Complex formation is mediated by main-chain and side-chain interactions of the so-called effector residues in the switch I region of RaplA.

[1]  W. Kabsch,et al.  Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.

[2]  M. L. Connolly Analytical molecular surface calculation , 1983 .

[3]  R. Read Improved Fourier Coefficients for Maps Using Phases from Partial Structures with Errors , 1986 .

[4]  C. Bugg,et al.  Structure of ubiquitin refined at 1.8 A resolution. , 1987, Journal of molecular biology.

[5]  C. Marshall,et al.  The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene product , 1988, Nature.

[6]  B. Olofsson,et al.  Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the 'effector' region. , 1988, Oncogene.

[7]  H. Kitayama,et al.  A ras-related gene with transformation suppressor activity , 1989, Cell.

[8]  T. Sasaki,et al.  Inhibition of the ras p21 GTPase-activating protein-stimulated GTPase activity of c-Ha-ras p21 by smg p21 having the same putative effector domain as ras p21s. , 1990, The Journal of biological chemistry.

[9]  A. Wittinghofer,et al.  Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. , 1990, Science.

[10]  Steven C. Almo,et al.  Time-resolved X-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysis , 1990, Nature.

[11]  C. Chothia,et al.  The structure of protein-protein recognition sites. , 1990, The Journal of biological chemistry.

[12]  W. Kabsch,et al.  Refined crystal structure of the triphosphate conformation of H‐ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. , 1990, The EMBO journal.

[13]  S H Kim,et al.  Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. , 1992, Science.

[14]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[15]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[16]  G. Rubin,et al.  The Drosophila Roughened mutation: Activation of a rap homolog disrupts eye development and interferes with cell determination , 1991, Cell.

[17]  A. Brunger Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. , 1992 .

[18]  London P. Cuatrecasas GTPases in Biology I , 1993, Handbook of Experimental Pharmacology.

[19]  M. Weber,et al.  Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. , 1993, Science.

[20]  S. Elledge,et al.  Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1 , 1993, Nature.

[21]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .

[22]  S. Cook,et al.  RapV12 antagonizes Ras‐dependent activation of ERK1 and ERK2 by LPA and EGF in Rat‐1 fibroblasts. , 1993, The EMBO journal.

[23]  F. McCormick,et al.  Structural requirements for the interaction of p21ras with GAP, exchange factors, and its biological effector target. , 1993, The Journal of biological chemistry.

[24]  G. Bokoch The Biology of Rap , 1993 .

[25]  M. Lawrence,et al.  Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.

[26]  M. Marshall,et al.  The effector interactions of p21ras. , 1993, Trends in biochemical sciences.

[27]  M. Nakafuku,et al.  GTP-dependent association of Raf-1 with Ha-Ras: identification of Raf as a target downstream of Ras in mammalian cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Warne,et al.  Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro , 1993, Nature.

[29]  M. Wigler,et al.  Complex formation between RAS and RAF and other protein kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Jonathan A. Cooper,et al.  Mammalian Ras interacts directly with the serine/threonine kinase raf , 1993, Cell.

[31]  J. Gibbs,et al.  Pharmaceutical research in molecular oncology , 1994, Cell.

[32]  S. Demo,et al.  ralGDS family members interact with the effector loop of ras p21 , 1994, Molecular and cellular biology.

[33]  Jonathan A. Cooper,et al.  A single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Fields,et al.  Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Troppmair,et al.  The ins and outs of Raf kinases. , 1994, Trends in biochemical sciences.

[36]  Sally J. Leevers,et al.  Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane , 1994, Nature.

[37]  J. Hancock,et al.  Activation of Raf as a result of recruitment to the plasma membrane. , 1994, Science.

[38]  David T. Jones,et al.  Protein superfamilles and domain superfolds , 1994, Nature.

[39]  D. Ringe,et al.  Structure of the human ADP-ribosylation factor 1 complexed with GDP , 1994, Nature.

[40]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[41]  D. Fry,et al.  Chemical shift assignments and folding topology of the Ras-binding domain of human Raf-1 as determined by heteronuclear three-dimensional NMR spectroscopy. , 1994, Biochemistry.

[42]  Marcel Spaargaren,et al.  Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  X. F. Zhang,et al.  Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues , 1994, Molecular and cellular biology.

[44]  N. Perrimon,et al.  Genetic and molecular analyses of mutations involved in Drosophila raf signal transduction. , 1994, The EMBO journal.

[45]  Benjamin Lewin,et al.  Genes for SMA: Multum in parvo , 1995, Cell.

[46]  Alfred Wittinghofer,et al.  Quantitative Analysis of the Complex between p21 and the Ras-binding Domain of the Human Raf-1 Protein Kinase (*) , 1995, The Journal of Biological Chemistry.

[47]  M. Wigler,et al.  Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.

[48]  W. Kabsch,et al.  Crystal structure of the nuclear Ras-related protein Ran in its GDP-bound form , 1995, Nature.

[49]  J. Bos,et al.  Regulation of Ras-mediated signalling: more than one way to skin a cat. , 1995, Trends in biochemical sciences.

[50]  X. F. Zhang,et al.  Identification of the sites of interaction between c-Raf-1 and Ras-GTP. , 1995, Oncogene.